Health Trials

Clinical trials

4

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Efficacy and Safety of AG2001 in Patients With Acute Bronchitis

This is a Phase 3, randomized, double-blind, active-controlled clinical trial designed to evaluate the efficacy and safety of AG2001 in patients with acute bronchitis. The primary objective is to demonstrate the superiority of AG2001 over two active comparators based on the change in Bronchitis Severity Score (BSS) at Day 4.

Participants needed: 300
Trial details
Phase: Phase 3Age: 19-64Biological sex: AllType: InterventionalSponsor: Ahn-Gook Pharmaceuticals Co.,LtdUpdated: Sep 30, 2025
Eligibility criteria

Adults aged ≥19 years to <65 years old [+6]

Chronic respiratory diseases (e.g., COPD, asthma, pneumonia, tuberculosis, lung... [+5]

Read more
Status: Recruiting

A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe

The objective of this study is to evaluate the effectiveness and safety of Pitavastatin/Ezetimibe FDC in patients with hypercholesterolemia.

Participants needed: 4,500
Trial details
Age: 19+Biological sex: AllType: ObservationalSponsor: Ahn-Gook Pharmaceuticals Co.,LtdUpdated: Aug 7, 2025Locations: 1
Eligibility criteria

Adults aged 19 years or older [+3]

Known hypersensitivity or history of hypersensitivity to any component of the in... [+7]

Read more
Status: Not yet recruiting

A Study to Evaluate the Safety and Pharmacokinetics of AG2304 Compared to Coadministration of AG23041 and AG23042

The objective of this study is to evaluate the pharmacokinetic characteristics of AG2304 in healthy subjects.

Participants needed: 70
Trial details
Phase: Phase 1Age: 19-65Biological sex: AllType: InterventionalSponsor: Ahn-Gook Pharmaceuticals Co.,LtdUpdated: Apr 8, 2025
Eligibility criteria

A healthy adults aged 19-65 years at the time of screening [+1]

Subjects who have taken the investigational drug within 6 months prior to the fi... [+1]

Read more
Status: Not yet recruiting

Bioequivalence Study of AG2202

The objective of this study is to evaluate the human bioequivalence of AG2202T and AG2202R.

Participants needed: 34
Trial details
Phase: Phase 1Age: 19+Biological sex: AllType: InterventionalSponsor: Ahn-Gook Pharmaceuticals Co.,LtdUpdated: Aug 14, 2024
Eligibility criteria

Subjects aged 19 years or older at the time of screening [+3]

Subjects who have taken drugs that induce or inhibit drug metabolizing enzymes w... [+2]

Read more